The proliferating cell nuclear antigen (PCNA), also known as cyclin or DNA-polymerase delta auxiliary protein, is a 36-kd nonhistone nuclear protein that functions as a cofactor for DNA-polymerase delta.lz PCNA levels increase rapidly in mid-G 1, remain elevated throughout S-phase, and begin to decrease from G2/M to G1-phase of the cell cycle.zJ2 PCNA represents a potentially useful tool for the study of tumor proliferation activity.I0
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Different techniques are used in human pathology to assess the proliferative activity of tumors, including 1) tritiated thymidine incorporation followed by autoradiography; 2) bromodeoxyuridine (BrdU) incorporation followed by anti-BrdU immunocytochemistry; 3) flow cytometric analysis; and 4) immunohistochemistry using cell-cycle-specific monoclonal antibodie~.~.'~ Investigations employing anti-PCNA antibodies are based on the fourth group of techniques.
Several recent papers in medical journals suggest that anti-PCNA antibodies could be employed to assess the proliferative activity of tumors.1~5~7-10~12 The results to date must be evaluated with caution. PCNA has a relatively long half-life (20 hours), and amounts of nondegraded protein can still remain in cells that have recently left the cell cycle.3 Thus, in assessing PCNA index (percentage of labeled nuclei), some authors have suggested counting only the strongly reactive nuclei' to avoid the inclusion of noncycling cells with cycling ones.
Among the available monoclonal antibodies to PCNA, clone PC 10 recognizes a formalin-fixed, paraffin-embedded resistant epitope of the protein, enabling the use of stored material that has been routinely processed.6,8 Some authors have suggested that fixation should last no longer than 48 hours, otherwise PCNA reactivity decreases.8
In the present study, the employment of clone PClO in veterinary oncology has been investigated, with regard to immunoreactivity in dogs and cats and reproducibility of the method on samples with known and unknown time of fixation as often happens in stored material for retrospective investigations. The percentage of labeled nuclei (PCNA index) was evaluated by computerized image analysis. Two different values of PCNA index were considered: one counting as positive only the strongly labeled nuclei (SP-PCNA index) and the other counting as positive all the labeled nuclei (TP-PCNA index). Both values of PCNA index were compared with mitotic index (number of mitoses per 1,000 cells).
To assess the reproducibility of the method, we selected from our files 140 samples (Table l) , 32 of which had a fixation time of 5 4 8 hours, which has been reported to optimize the immunostaining,8 and 108 with an unknown time of fixation. All samples were fixed in formalin and embedded in paraffin. Four-micrometer-thick sections were cut and air dried overnight at room temperature (RT) to assist adherence to glass slides.8Jz The sections were then deparaffinized and rehydrated. Endogenous peroxidase was blocked by 0.3% hydrogen peroxide for 30 minutes. After a wash in Tris buffer, the sections were preincubated with normal goat serum (Dako, Milan, Italy) (dilution 1 : 20) for 30 minutes at RT. Sections were then incubated with mouse anti-PCNA antibody (Labometncs, clone PC10, Milan, Italy) at a dilution of 1 : 100 overnight at RT. The second-stage antibody was a goat antimouse biotinylated IgG (Bio SPA, Milan, Italy) used at a dilution of 1 : 100 for 30 minutes at RT followed by incubation with ABComplex (Dako, Milan, Italy) for 30 minutes at RT. Diaminobenzidine (0.04% for 10 minutes) was used as chromogen. After a rapid wash in Tris buffer, the sections were counterstained with toluidine blue. The sections were hydrolyzed in 5 N HCl for 20 minutes at RT, rinsed twice ( 5 minutes each time) in distilled water (DW), and then immersed for 10 minutes in a solution of 0.5 g toluidine blue 0 in 100 ml of bleach solution (90 ml of bidistilled water, 5 ml 1 N HCl, 5 ml 10% sodium metabisulfite). The immersion solution was prepared 12-24 hours before use, kept in the dark at RT, filtered before use, and disposed of immediately after use. After the toluidine blue solution step, the sections were immersed twice (1 minute each) in bleach solution, rinsed in DW, dehydrated, and mounted with dibutilphthalate-xylene (DPX; BDH, Poole, England).
Control sections were incubated in buffer instead of primary antibody dilution.
Quantitation of PCNA immunostaining was performed using an image cytometer, consisting of a B&V CCD videocamera (AVC-DSCE, Sony Corp., Kangawa-ken, Japan) connected to an 80386/25 MHz (Intel Corp., Hillsboro, OR) desktop computer through an image grabber card (Microeye IC, Digithurst, Royston, UK). Images were digitized at 5 12x 480-pixel resolution with 256 (8 bit) gray levels and visualized on a color multiscanning monitor driven by a super VGA card (Eva/lO24, Tseng Laboratories, Taipei, Taiwan). Analytical software for image processing was provided by Dr. P. Chieco, Institute of Oncology, Bologna, Italy. * Known time of fixation is 5 4 8 hours; only cases with positive reaction to PCNA are numbered in the group with unknown time of fixation.
Ten fields per case were analyzed, including fields with the highest percentage and the lowest percentage of reactivity to PCNA. In each of the 10 fields, a first image of the total nuclear area was mapped using a red (630/ 10-nm bandpass) filter. The second and third areas were mapped using a blue (490/ 1 0-nm bandpass) filter. These areas included the strongly labeled nuclei and the entire count of stained nuclei, respectively. All images were obtained using a 25 x objective and a 10 x eyepiece, yielding a final magnification of 250 x .
In each field, only the epithelial or carcinomatous part of the tumor was considered. The remaining cells of the field, such as inflammatory cells, stromal cells, and myoepithelial cells, were erased, so their nuclei did not appear in the total nuclear area of the field. The values of PCNA index are expressed as a percentage of labeled nuclei (totally or only strongly) compared with the total nuclear area.
To calculate the mitotic index, in each case we evaluated the mean area of a nucleus and the total number of mitoses (T No. Mit) counted in the 10 fields analyzed for PCNA immunostaining quantification. Mitotic index was calculated as follows:
total nuclear area of the 10 fields mean area of a nucleus n = ' where n = number of cells present in the total nuclear area of the 10 chosen fields. Therefore, n mitotic index = No. Mit x 1,000.
Statistical analyses (linear regression and Spearman rank correlation coefficient) were performed using CSS Statistic (Statsoft, Tulsa, OK).
Of the 140 samples, 38 were discarded because they revealed negative or weak reaction to PCNA and 102 were positive. All the discarded cases belonged to the group with unknown time offixation. Ofthe 102 positively stained cases, 70 belonged to the unknown time group (70/102) and 32 belonged to the group with fixation time of 5 4 8 hours.
PCNA reactivity was expressed as diffuse nuclear staining. Variable staining was frequently observed in areas with high and low proliferative activity in the same tumor. A clear gradation in the intensity of staining appeared, and two main populations of immunostained nuclei could be seen: strongly labeled nuclei and less intensely labeled nuclei. Cytoplasmic staining was particularly prominent in mitotic cells but was sometimes seen in nonmitotic cells. The negative nuclei were stained light blue, whereas the condensed chromatin of mitotic cells was dark blue, thus enabling the performance of the mitotic count easily using a 25 x objective.
In linear regression analysis, the two PCNA parameters (SP-PCNA index and TP-PCNA index) used to assess the proliferative activity showed a highly significant correlation ( P < 0.0001) (Fig. 1) . In some cases, the values of PCNA indices were different from expected, showing higher or lower values in respect to the trend of the regression. A positive correlation was also found between both the values of PCNA index and mitotic index in linear regression analysis ( P < 0.0001) (Fig. 2) .
PC 10 anti-PCNA antibody has shown positive immunoreactivity with dog and cat mammary neoplasms, thus indicating its usefulness for quantifying the proliferating fractions of these tumors. This technique is faster and simpler than other methods in use (thymidine labeling index, BrdU uptake, flow cytometry). Immunohistologic methods of assessing cell proliferation are also advantageous over the others because of the maintenance of cellular and tissue architecture.* In our investigation, out of the 140 samples stained for PCNA, only 102 showed a clear positive staining, and 38 were discarded because they showed no or weak reaction to PCNA. Out of the 102 positively stained cases, 32 had a known period of fixation of 48 hours or less, and all of these 32 cases showed strong immunoreactivity to PCNA. This finding provides valuable evidence of the repeatability of the method used and is consistent with the report of Hall et al., who suggest that fixation should last no longer than 48 hours.* Therefore, one reason why 38 out of 140 of the cases considered did not stain could be because it often takes longer than 48 hours for the fixed surgical sample to reach the laboratory. Thus, the use of stored samples in retrospective investigations can give good results for immunoreactivity to PCNA (out of 108 cases with an unknown time of fixation, 70 were reactive), even if some cases are nonreactive because prolonged fixation has destroyed the antigen.
Immunostaining was confined to the nuclei. Sometimes the stain appeared in nonmitotic cells, probably expressing cytoplasmic synthesis or breakdown of the protein, whereas the diffuse staining throughout the mitotic cells is explained by loss of the nuclear membrane during mitosis.* Quantitative evaluation of proliferative activity was accomplished using an image analyzer, which is a much faster method than using an eyepiece graticule and visual estimation. Fitting the immunolabeling with the computerized image analysis toluidine blue counterstain has two main advantages: 1) it stains only the nuclei but neither the cytoplasm nor the stroma, allowing the evaluation of the nuclear area only; and 2) toluidine blue has high affinity for the nuclei with condensed ~h r o m a t i n ,~ so the mitotic count is easier to perform on the same field chosen to quantitate the PCNA immunostaining.
In most cases, our investigation did not show differences in using SP-PCNA index or TP-PCNA index to assess the proliferative activity. Recent reports vary as to how the scoring process is performed. PCNA quantitation on human cell lines has revealed that the highest concentration of PCNA is present during the S-phase of the cell cycle; its level decreases during G2, is lowest during mitosis, and increases during G1.2J1 In this way, even if PCNA is considered a relatively S-phase-specific antigen, it is present at detectable levels in all cycling cell^.^^^^ The varying levels of PCNA during the cell cycle could explain the pattern of immunostaining normally seen: the strongly positive nuclei belong to cells in S-phase, and more weakly positive nuclei belong to cells with antigen persisting in other cell-cycle phases.6 Battersby and Anderson, comparing the values of proliferation assessed by anti-PCNA antibody (clone 19A2) and by autoradiography in human breast cancers, concluded that by counting all the labeled nuclei with anti-PCNA antibody the values would be too high if compared with those obtained by the other parameter of pro1iferation.l They scored only the nuclei that were strongly reactive to PCNA to get PCNA index and had a close correlation with the S-phase evaluation by thymidine labeling index. In contrast, Garcia et al., using the same anti-PCNA antibody to assess the proliferative activity of several human tumors including breast cancers, counted as positive all the labeled nuclei and showed close correlation with the S-phase fraction measured by flow ~ytometry.~ To date, no reports are available on comparison of the difference in values of PCNA index assessed as SP-PCNA or TP-PCNA indices. Our linear regression analysis of the SP-PCNA and TP-PCNA indices suggests that the TP-PCNA index provides for a more objective scoring process than does the SP-PCNA index, as already assessed by other authors.'
Although in most cases there was a high degree of correlation between the two PCNA indices, some cases did not comply to this rule and showed higher or lower values of PCNA indices than expected by linear regression. This discrepancy could be due to the rate of proliferation of a given Vet Pathol 32:1, 1995 tumor. Hall et al. showed that the number of cells immunoreactive to PCNA is very low in cell populations with low rates of BrdU incorporation, whereas in highly proliferative cell lines almost all the cells are immunoreactive to PCNA and there is no relationship with the cell cycle phases as judged by DNA content.8 Our cases with a higher than expected TP-PCNA index could be the extreme condition of rapidly cycling tumors, in which more numerous cells than expected are positive, both because of the long half-life of PCNA and because all the cycling cells have no tendency to transform to a quiescent (GO) state. Cases with lower than expected values of PCNA indices could be explained as the extreme condition of slowly growing tumors. In these cases, a consistent portion of cycling cells transform to a quiescent state, so the TP-PCNA index, as well as the SP-PCNA index, is lower than expected. A PCNA half-life of 20 hours is reported for cells that transform from cycling to a quiescent state, whereas the half-life is shorter (8 hours) for cycling cell^.^.^^ If the PCNA index could be linked to a parameter enabling to measure the rate of proliferation, workers could assess how much background staining (noncycling cells positively stained) affects different rates of proliferation. Hall et al. suggested that factors other than the rate of proliferation can have an effect on the PCNA background and reported that autocrine and paracrine growth factors influence PCNA gene expression,8 which induces overexpression of PCNA immunoreactivity, as mainly observed in breast and pancreatic tumors. Comparison of the state of proliferation as assessed by anti-PCNA immunoreactivity with an independent parameter able to evaluate the rate of proliferation (such as BrdU uptake) should indicate whether only autocrine and paracrine factors or also the rate of proliferation influence PCNA stability and consequently the background staining.
Both PCNA indices were closely correlated with mitotic index, which is an older but still valuable method of cell proliferation a s s e s~m e n t .~J * .~~ PCNA index is a useful parameter for assessing the proliferative activity of tumors and can be used as a measure of the strongly labeled nuclei or of all the positive nuclei; this latter measure appears to be more objective.
